Skip to main content
AVD logo

AVD · American Vanguard Corp

Track AVD — free
$0.84 -0.04 (-4.18%)
Market Cap
$25.89M
Shares
29.55M
Volume · Nov 13 324.47K Avg daily vol (3M) 422.58K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.88 Open$0.90 Day$0.85–0.93 52W close$0.82–5.41 Avg vol 30d539K Short int301K · 1.0% of shares · 1.0d Short vol43% Last earningsNov 9, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 9

Up next

Mar 15, 2027 Est · unconfirmed · in 17 wks

Latest documents

2026
Nov 10
Current report 8-K Events of Nov 9
Loss widens as full-year outlook is cut

American Vanguard reported a widened third-quarter net loss of $17.7 million versus $12.4 million last year and lowered full-year guidance to $500 million-$530 million in sales and $36 million-$40 million in Adjusted EBITDA.

Financial results, Regulation FD disclosure
3 source passages
American Vanguard Reports Third Quarter 2026 Results Net loss of $17.7 million, as compared to $12.4 million; Revise Full-Year Outlook; Adjusted EBITDA $36 million to $40 million on Sales of $500 million to $530 million Open the document at this passage
Nov 9
Earnings call
Cuts 2026 revenue and adjusted EBITDA guidance

American Vanguard lowered 2026 revenue guidance to $500 million to $530 million and adjusted EBITDA guidance to $36 million to $40 million, citing weaker international results and rising fuel and raw-material costs.

3 source passages
Welcome to the American Vanguard Third Quarter 2026 Earnings Conference Call. We now expect full-year revenue to be in the range of $500 million to $530 million, down from our prior range of $530 to $550 million. For adjusted EBITDA, we now expect this to come in the $36 million to $40 million range, down from our prior forecast of $44 million to $48 million. The primary drivers of this change are weaker results from our international business. Relative to prior expectations and the inability to pass along price increases fast enough to keep up with the rising fuel costs and increases in underlying raw materials. Open the document at this passage
Nov 9
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarter sales fell 9% as net loss deepened to $17,668

American Vanguard reported third-quarter net sales down 9% and a net loss of $17,668 versus $12,358, as gross profit fell 23%. International sales declined 17%.

Read from the MD&A section
5 source passages
Overall net sales during the quarter declined by 9% over the comparable period last year. With lower sales, gross profit decreased 23% quarter-over-quarter. Our overall net loss for the three months ended September 30, 2026 was $17,668 or ($0.61) per basic and diluted share, as compared to net loss of $12,358 or ($0.43) per basic and diluted share in the same quarter of 2025. This performance included decreases in net sales of both U.S. Crop and U.S. Specialty (both down 2%) and International business (down 17%). The Company continually re-assesses the business risks, and as part of that process detailed a range of risk factors in the disclosures in American Vanguard’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed on March 16, 2026. Open the document at this passage
Oct 1
Current report 8-K
Director or officer change, or executive pay, Regulation FD disclosure

American Vanguard Corporation appointed Matthew Horwath Chief Financial Officer effective October 1, 2026, succeeding David Johnson, who became Chief Accounting Officer. Horwath’s annual base salary is $450,000, with a target annual bonus of 60% of base salary.

Sep 30
Annual report 10-K/A FY2025, ended Dec 31
Annual report for FY2025

American Vanguard Corporation amended its auditor’s report to confirm coverage of three years ended December 31, 2025 and correct accrued program costs from $54.6 million to $52.2 million.

Revenue $515.11M ▼ 5.9% Net loss $49.88M Diluted EPS -$1.75
Read from the first part of this long document
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$499.39M
Trailing 12 months
Net income (TTM)
−$59.89M
Trailing 12 months
Revenue growth YoY
-9.2%
Year over year
Operating margin
-5.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$206.47M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.9%
Year over year · more shares
Price change (1Y)
-82.8%
Trailing year
Short interest
1.0%
Latest settlement · 1.0 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Nov 9, 2026
Q3 FY26

TL;DR. Fourth-quarter sales and adjusted EBITDA are forecast to grow, portfolio additions and new products support growth, footprint consolidation is saving money, working capital and inventory improved, and year-to-date U.S. sales increased. However, full-year guidance was reduced, third-quarter sales, margins, profitability, and international sales deteriorated, and transportation costs remain a headwind.

Bullish
  • + Fourth-quarter sales and adjusted EBITDA are forecast to grow year over year. new
  • + Portfolio additions are projected to add annualized revenue over the next 12 months. new
  • + The new-product pipeline includes 10 launches year to date and the planned U.S. launch of Duro LQ in the fourth quarter. new
Bearish
  • − Full-year revenue and adjusted EBITDA guidance was lowered. new
  • − Third-quarter sales declined 9% and nine-month sales declined 4%. new
  • − Third-quarter gross margin contracted as cost pressures outweighed manufacturing improvements. new
  • − International sales declined sharply because El Niño weather conditions affected demand. new

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −67%
below
Price vs 50-day avg −42%
below
RSI (14) 28
oversold
MACD trend Positive
52-week position 1%
near low
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Very Weak
1-month return −17%
trailing
6-month return −67%
trailing
YTD return −77%
this year
Relative strength −67%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow Distributing
74 of 106 funds reported for Sep 30 · net -646.4K sh shares · +3 new
Insider flow Distributing
Net -$1.2M over 90 days · 100% sells
Short interest Falling
1.02% of shares out · ▼ -1.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
106 holders — near 3-yr low, contrarian setup
Squeeze score 38
low risk · 0–100
Fundamentals
Fair
Revenue growth −6%
Y/Y
Gross margin 29%
expanding
EPS growth +61%
Y/Y
Balance sheet $161.6M
net debt
Quant / Vol
risk profile
Very High
Volatility 73%
annualized · 1-yr
Max drawdown −85%
past year
ATR 11.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 0 of last 3
Latest guidance · from the 8-K filed Nov 10, 2026
Full-Year Outlook
Adjusted EBITDA Non-GAAP Lowered $36M – $40M
Aug 11, 2026 $44M – $48M changed to Nov 10, 2026 $36M – $40M
Sales Lowered $500M – $530M
Aug 11, 2026 $530M – $550M changed to Nov 10, 2026 $500M – $530M
prior FY $515.11M midpoint −0.0% Y/Y
by 2030
Annualized revenue from new products $100M
Annualized revenue $100M
next 12 months
Annualized revenue $15M – $20M
a year
Savings at least $4M
fourth quarter of 2026
Net sales Initiated $166M
prior qtr $108.38M midpoint +53.2% QoQ
Adjusted EBITDA Non-GAAP Initiated $21M
fourth quarter
Prepayment and early pay collections $45M
by the back half of 2028
Annualized run rate of more than $600 million in sales at least $600M
prior FY $515.11M midpoint +16.5% Y/Y
Previous outlook earlier release · from the 8-K filed Aug 11, 2026

Still-open targets the latest release did not restate under the same label.

Annualized savings from L.A. production facility rationalization · going forward at least $4M
Guided vs delivered · last 3 settled
Net sales full year 2025
guided $520M – $535M
$515.11M Miss −2.3%
Sales full year 2024
guided $565M – $580M
$547.31M Miss −4.4%
Net sales 2023 Range
guided $580M – $590M
$579.37M Miss −1.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
3 · 2 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−67% Bearish
Price vs 50-day avg
−42% Bearish
RSI (14)
28 Neutral
MACD trend
Positive Bullish
52-week position
1% Bearish
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow Distributing
74 of 106 funds reported for Sep 30 · net -646.4K sh shares · +3 new
Insider flow Distributing
Net -$1.2M over 90 days · 100% sells
Short interest Falling
1.02% of shares out · ▼ -1.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
106 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1 Now $1 · 1% Range high $5
vs 200-day avg -67% vs 50-day avg -42%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $17M first half 2026 —
Adjusted operating expenses non-GAAP $33.5M Q2 FY2026 —
Operating expenses excluding the expenses associated with transformation and product liability c non-GAAP $33.11M For the Three Months Ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Agricultural Inputs — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AVD
American Vanguard Corp
this stock
$25.89M -77.1% -5.9% — 1.0%
NTR
Nutrien Ltd.
$33.78B +15.4% — — 1.8%
CF
CF Industries Holdings, Inc.
$18.30B +61.7% +19.3% 8.9 6.1%
YARIY
Yara International ASA
$10.87B +4.7% — — 0.0%
MOS
Mosaic Co
$6.97B -9.0% +8.4% — 11.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
85
% held
47.7%
Reported
74 of 106
Top holder
WELLINGTON MANAGEMENT GRO…
Held Float
View
Held by Funds
Fund positions
71
View
Short & Settlement
Short Interest Falling
Shares short
301.2K
Days to cover
1.0d
Change
-4.6K sh
View
Short Volume
Short vol %
43%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
554
Value
$781
As of
Oct 13, 2026
View
Off-Exchange
Off-exchange %
76.7%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$1.2M
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$515.1M
Net income (FY)
$-49.9M
EPS diluted
$-1.75
View
Buybacks
Authorized
shares 300.0K
Remaining
shares 0
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 10, 2026
This year
13

American Vanguard reported a widened third-quarter net loss of $17.7 million versus $12.4 million last year and lowered full-year guidance to $500 million-$530 million in sales and $36 million-$40 million in Adjusted EBITDA.

View
Proposed Sales
Value
$32.1K
Shares
6.0K
Filed
Sep 4, 2025
View
Earnings & Events
Webcasts
Last webcast
Nov 9, 2026
View
Investor Relations
Latest news
American Vanguard Reports Third Q…
Published
Nov 9, 2026
View

Performance

5D 20D 120D MTD YTD
AVD -9.0% -17.4% -66.9% -20.4% -77.1%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -11.6% -16.2% -67.4% -20.2% -87.7%

Capital returns

Latest dividend
$0.03 / share · ex Jun 26, 2024
Raised 20%
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Full dividend history
Buyback program · as of Mar 31, 2024
Authorized
shares 300,000
Spent (derived)
shares 300,000
Remaining
shares 0
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 5981 CUSIP 030371108 13F (30d) 67 filings 46 filers Visit website Investor relations